Sari S. Khaleel, MD, MSC

MSKCC

Sari Khaleel is a first year urologic oncology fellow at MSKCC. His research interest include translational biomarkers and clinical outcome research for RCC. He completed his double major in biology and computer science degree at Georgetown University, followed by a Master's degree in bioinformatics and computational biology at the University of Delware. He then completed his urology residency at the University of Minnesota. His prior research projects included evaluation of the quality of systematic reviews in urology, perioperative management of cystectomy patients, and cost effectiveness assessment and improvement of endourologic procedures.

Disclosure information not submitted.

Presentation(s):

• PD01-08: Comparison of Mutational Profile of Primary versus Organ-specific Metastatic Tumors in Clear Cell Renal Cell Carcinoma

  Friday, May 13, 2022
  8:10 AM – 8:20 AM

• MP24-07: Adverse Radiologic and Pathologic Features Impact Survival Outcomes for Small Renal Masses Following Nephrectomy

  Saturday, May 14, 2022
  8:45 AM – 10:00 AM

• PD59-01: BAP1 Loss is Associated with Metastasis in Advanced Clear Cell Renal Cell Carcinoma

  Monday, May 16, 2022
  1:00 PM – 1:10 PM

• PD59-02: Prostate Specific Membrane Antigen Expression is Associated with Angiogenesis and Tyrosine Kinase Inhibitor Response in Clear cell Renal Cell Carcinoma

  Monday, May 16, 2022
  1:10 PM – 1:20 PM

• PD59-09: Outcomes of Cytoreductive Nephrectomy Followed by Active Surveillance in Metastatic Renal Cell Carcinoma

  Monday, May 16, 2022
  2:20 PM – 2:30 PM